Other Information Technology · Wilmington, DE · Founded 2024 · Privately Held (backing)
Developer of a biotech platform designed to apply generative artificial intelligence to biological data for advancing drug discovery and development. Converge Bio is based in Wilmington, DE and was founded in 2024. It was valued at $90 million at its early-stage round in Jan 2026, the last priced event on record. It has raised $30.5 million across 1 recorded round; the latest was a $25 million Series A in Jan 2026.
These 6 firms already write checks for companies like Converge Bio in other information technology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.